You just read:

Sophiris Bio Reports Top-Line Interim Safety and Biopsy Findings For its Phase 2b Clinical Trial of Topsalysin in Localized Prostate Cancer

News provided by

Sophiris Bio Inc.

Jun 25, 2018, 08:37 ET